Ginski Mark J 4
4 · VistaGen Therapeutics, Inc. · Filed Feb 2, 2021
Insider Transaction Report
Form 4
Ginski Mark J
SENIOR VP, HEAD OF CMC
Transactions
- Award
Stock Options (Right to Buy)
2021-02-01+200,000→ 200,000 totalExercise: $2.14Exp: 2031-02-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares vest on the first anniversary of the grant date, and the remainder vests in 36 equal monthly installments thereafter over a period of three (3) years, becoming fully vested on February 1, 2025.